Crossmark

Are immunotherapies for Huntington’s disease a realistic option?

Crossref DOI link: https://doi.org/10.1038/s41380-018-0021-9

Published Online: 2018-02-27

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Denis, Hélèna L.

Lauruol, Florian https://orcid.org/0000-0001-5919-1372
Cicchetti, Francesca
License Information

Text and Data Mining valid from 2018-02-27
More Information

Article History

Received: 4 October 2017

Revised: 22 December 2017

Accepted: 15 January 2018

First Online: 27 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.